Business Wire: Lantern Pharma to Host Virtual KOL Webinar on the Treatment of Pediatric Cancers During Childhood Cancer Awareness Month, featuring Peter Houghton, Ph.D.
September 20, 2022Webinar to be hosted on Thursday, Sept. 22, 2022, at 12:00 p.m. ET, register here. Dr. Houghton will discuss challenges in drug development for pediatric cancers and preliminary results from Lantern’s drug candidates in preclinical pediatric cancer models with unmet clinical needs. September 19, 2022 08:50 AM Eastern Daylight Time DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: [...]
September 19, 2022Talk Title: Structured RNAs restrict the N6-adenine methylation (m6dA) activity of human METTL3-METTL14
September 19, 2022Good afternoon, everyone! Please join us and Dr. Alexander J.R. Bishop in congratulating Henry Miller on his passing his PhD Defense with honors! Way to go Henry!!!!!
UT Health SA Newsroom: The University of Texas Health Science Center at San Antonio moves up in Forbes Best-In-State Employers list
August 31, 2022Posted on August 29, 2022 at 10:39 am. Shared by Steven Lee Now ranked 12th; fifth among health care/social employers. The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has jumped to 12th on Forbes magazine’s list of Best-In-State Employers 2022, from 34th last year. UT Health San Antonio made the ranking of [...]
August 24, 2022The National Cancer Institute (NCI) has recently awarded an R50 Research Specialist Award to Dr. Zhao Lai, Associate Professor/Research, Director of the Next-Generation Sequencing Shared Resource (NGSSR) in the NCI-designated Mays Cancer Center (MCC). This award, over five years, supports the development of a stable research career for Dr. Lai, an exceptional scientist who will [...]
Business Wire: Lantern Pharma Reports Second Quarter 2022 Financial Results and Operational Highlights, Scientific Collaborations Updates (Houghton)
August 9, 2022During Childhood Cancer Awareness Month in September, Lantern will host a KOL webinar featuring Dr. Peter Houghton, Ph.D., a leading expert in childhood cancers at the Greehey Children's Cancer Institute at the University of Texas San Antonio Health Science Center. The webinar will focus on challenges in drug development for pediatric cancers and preliminary results from [...]
June 24, 2022Abstract Atypical teratoid/rhabdoid tumors (AT/RT) of the brain and malignant rhabdoid tumors of the kidney (RTK) compose a group of highly malignant pediatric cancers known as malignant rhabdoid tumors (MRT). Both subtypes are characterized by the biallelic loss of the SMARCB1 gene (member of the human SWI/SNF complex), which is thought to function as a [...]
Angelina Vaseva, PhD, to Receive Voelcker Fund Award to Research Type 2 RAF Inhibitors for the Treatment of NF1-Associated MPNST
June 15, 2022Angelina Vaseva, Ph.D. Greehey CCRI Principal Investigator Assistant Professor, Molecular Medicine "Angelina Vaseva, PhD, is an assistant professor in the Department of Molecular Medicine and the Greehey Children’s Cancer Research Institute. Dr. Vaseva is receiving $350,000 over three years for her award as she received $100,000 last year as a Voelcker Fund Pilot Research Award [...]